Cost-effectiveness review that would allow the cost of medical abortion pills to be covered by Canadian provinces to go ahead

Celopharma Inc, the company that is bringing the combined abortion pill package of mifepristone+misoprostol to Canada is going ahead with a crucial cost-effectiveness review by the Common Drug Review (CDR) that could clear the way for provincial drug plans to cover the CAN $300 cost of the medication, according to Health Canada.

Trudeau government removes restriction on international development funds being used for abortion services

The Justin Trudeau government has removed a restriction that prevented federal foreign aid dollars being used for abortion services in other countries. The government of former Prime Minister Stephen Harper had committed billions in Canadian funds for its global maternal, child and newborn health, but banned use of Canadian government money to provide abortion services.

The Minister for the Status of Women has expressed support for protecting access to abortion clinics in Quebec but the Minister for International Development has not earmarked development funding for safe abortion

posted in: Canada, Feature, Newsletter | 0

Canada has announced millions of dollars in funding for UNFPA’s work, but no funds have been earmarked for safe abortion care in developing countries. International aid for safe abortion care was banned in 2010 by the previous conservative government and strongly denounced by opposition.

Registered office: c/o Promsex, Av. José Pardo 601, Oficina 604, Miraflores, Lima 18, Perú

© 2016 International Campaign for Women's Right to Safe Abortion.

WordPress Theme by Kadence Themes. Website by Kestrel Copy